|
SCOR in Neurobiology of Sleep--Intermediate Traits for Sleep Apnea Clinical Trials Information presented on Clinical Trials Search is not intended to be a substitute for qualified health advice, trips or treatment by using a genuine doctor. We aren't doctors. Always consult your mD on SCOR in Neurobiology of Sleep--Intermediate Traits for Sleep Apnea conditions. Clinical Trials Search.org is a site committed to listing clinical research studies in human subjects. SCOR in Neurobiology of Sleep--Intermediate Traits for Sleep Apnea Clinical research trials and SCOR in Neurobiology of Sleep--Intermediate Traits for Sleep Apnea health trials take place in a lot of of cities across the US. A clinical trial or clinical study is a research project with human volunteer subjects. Clinical drug trials and pharmaceutical clinical trials generally measure the potency of new drugs. The aim of the studies / projects is to answer specific human medical questions. Clinical trials are a popular manner for physicians, government agencies, and private sector corporations to discover remedies for all kinds of circumstances, like SCOR in Neurobiology of Sleep--Intermediate Traits for Sleep Apnea. SCOR in Neurobiology of Sleep--Intermediate Traits for Sleep Apnea Clinical Trials and other clinical trials allow for volunteers to have health treatment alternatives before they are available to the general public. Many times the test subjects obtain treatment for without cost, and occasionally they are paid for their time. Sometimes there is a cost for a SCOR in Neurobiology of Sleep--Intermediate Traits for Sleep Apnea clinical trial. Subjects oftentimes recieve the most effective healthcare possible for their SCOR in Neurobiology of Sleep--Intermediate Traits for Sleep Apnea condition. Hazards are a reality, however, and could include additional or frequent doctor visits, healthcare dangers (perhaps life-threatening), and/or the treatment being ineffective. Trials are federally governed with exacting guidelines to protect clinical trials subjects.
|
|
|
|
|
|
|
Home > "S" Clinical Trials Conditions > SCOR in Neurobiology of Sleep--Intermediate Traits for Sleep Apnea  SCOR in Neurobiology of Sleep--Intermediate Traits for Sleep Apnea
SCOR in Neurobiology of Sleep--Intermediate Traits for Sleep Apnea
For Condition: Sleep Apnea Syndromes,Lung Diseases
Status: Completed
Sponsor(s): National Heart, Lung, and Blood Institute (NHLBI) ,
Synopsis: To determine intermediate traits for sleep apnea in a case-control study.
Details: BACKGROUND: Sleep apnea is a common condition that affects 4 percent of middle-aged males and 2 percent of middle-aged females. There is recent evidence that there is a genetic influence because first degree relatives of patients with this disorder have an increased risk of having obstructive sleep apnea. The basis for this increased familial risk is undefined. The investigators postulated that there were three specific intermediate traits, each of which reduced upper airway size, thereby increasing the risk of sleep apnea. These intermediate traits included: a) particular distribution of fat in the neck; b) craniofacial structure; and c) size of critical soft tissues in the airway (soft palate, tongue, lateral pharyngeal walls). All of these risk factors could be assessed quantitatively using advanced magnetic resonance imaging and novel volumetric image analysis techniques that had been developed.. The study was one project within a Specialized Center of Research in Neurobiology of Sleep and Sleep Apnea. DESIGN NARRATIVE: The case-control study identified the structural risk factors for sleep apnea. The study was complemented by studies in siblings of the patients and controls in order to identify those traits that demonstrated family aggregation not explained by shared environmental factors. The investigators believed that these structural risk factors would interact to increase the risk of sleep apnea. The elucidation of upper airway structural risk factors should provide the basis for developing new, more effective techniques for screening patients for sleep apnea and provide the basis for performing future DNA analyses aimed at identifying the genetic loci for these risk factors. The specific aims were: 1) to quantify upper airway craniofacial structure, soft tissues and regional fat deposition using three dimensional magnetic resonance imaging in order to determine the intermediate traits associated with obstructive sleep apnea utilizing a case control design in normals and apneics; and 2) to determine the upper airway structural risk factors for sleep apnea that demonstrated family aggregation and were most likely to have a genetic component by comparing probands, siblings of probands, neighborhood controls and siblings of neighborhood controls. The resources included an extensive clinical sleep practice, sophisticated NM imaging techniques, novel volumetric computer graphics image analysis and expertise in molecular epidemiology, craniofacial structure, and the genetics of obesity.
Eligibility:
Study Type: Observational, Natural History, Case Control
Minimum Age/Maximum Age: /
Genders: Both
Protocol Entry Criteria: No eligibility criteria
Total Enrollment:
Location and Contact Information:
Overall Study Official:
Richard.Schwab, , University of Pennsylvania
Additional Information:
Study ID Numbers: 5029;
Study Start Date: September 1998
Record last reviewed: March 2004
Additional information available at: clinicaltrials.gov
Clinicaltrials.gov Reference link: NCT00005511
Other Sleep Apnea Syndromes Studies:
1. SCOR in Neurobiology of Sleep--Intermediate Traits for Sleep Apnea
2. CEP-10953 for Treatment of Narcolepsy, Obstructive Sleep Apnea/Hypopnea Syndrome, or Chronic Shift Work Sleep Disorder
3. Validation and Exploration of Sleep and Mood Predictors
4. Sleep Heart Health Study (SHHS)
5. Sleep Apnea in a Non-Clinical Population
Related Studies:
Other Sleep Apnea Syndromes Clinical Trials
Other Clinical Trials
Other Clinical Trials
SCOR in Neurobiology of Sleep--Intermediate Traits for Sleep Apnea
|
|
|
|
|
|
|
|
